Contract development and manufacturing organization (CDMO) Rentschler Biopharma has announced a partnership with ...
But cell and gene therapies (CGTs) are catching up. During Cell and Gene Therapy International Europe 2025, held in Berlin, ...
Stéphane Bancel, CEO of vaccine maker Moderna, addressed shareholders in a letter that dissected the events of 2025 while ...
Contract development and manufacturing organization (CDMO) Samsung Biologics made a splash at the end of 2025, acquiring ...
HCPs are unwanted impurities requiring removal during manufacturing, but new trehalose technology significantly reduces HCPs ...
With the first half of this discussion in BPI’s October 2025 issue, I introduced the basics of phased stability testing, a fundamental component of ensuring biopharmaceutical quality, safety, and ...
Therapeutics firm Tivic Health, has acquired the manufacturing and development assets of Scorpius Biomanufacturing. The company will leverage the assets to launch Velocity Bioworks, a subsidiary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback